Indolyl aryl sulfones bearing the 4,5-difluoro (10) or 5-chloro-4-fluoro (16) substitution pattern at the indole ring were potent inhibitors of HIV-1 WT and the NNRTI-resistant strains Y181C and K103N-Y181C. These compounds were highly effective against the 112 and the AB1 strains in lymphocytes and inhibited at nanomolar concentration the multiplication of the IIIBBa-L strain in macrophages. Compound 16 was exceptionally potent against RT WT and RTs carrying the K103N, Y181I, and L100I mutations.

Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity / Regina, Gl; Coluccia, A; Piscitelli, F; Bergamini, A; Sinistro, A; Cavazza, Antonella; Maga, G; Samuele, A; Zanoli, S; Novellino, E; Artico, M; Silvestri, R.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 50:(2007), pp. 5034-5038. [10.1021/jm070488f]

Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity

CAVAZZA, Antonella;
2007-01-01

Abstract

Indolyl aryl sulfones bearing the 4,5-difluoro (10) or 5-chloro-4-fluoro (16) substitution pattern at the indole ring were potent inhibitors of HIV-1 WT and the NNRTI-resistant strains Y181C and K103N-Y181C. These compounds were highly effective against the 112 and the AB1 strains in lymphocytes and inhibited at nanomolar concentration the multiplication of the IIIBBa-L strain in macrophages. Compound 16 was exceptionally potent against RT WT and RTs carrying the K103N, Y181I, and L100I mutations.
2007
Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activity / Regina, Gl; Coluccia, A; Piscitelli, F; Bergamini, A; Sinistro, A; Cavazza, Antonella; Maga, G; Samuele, A; Zanoli, S; Novellino, E; Artico, M; Silvestri, R.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 50:(2007), pp. 5034-5038. [10.1021/jm070488f]
File in questo prodotto:
File Dimensione Formato  
J Med Chem 2007.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 69.63 kB
Formato Adobe PDF
69.63 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/1850802
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 57
  • ???jsp.display-item.citation.isi??? 51
social impact